Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
All Nursing Boot Camp Posters

St. Vincent Medical Center, Portland, OR

2015

PSVMC Post Operative Exploratory Study June-July 2015
Peggy Boyles
Providence St. Vincent Medical Center, Peggy.Boyle@providence.org

Gina Garland
Providence St. Vincent Medical Center, Gina.Garland@providence.org

Theresa Nelson
Providence St. Vincent Medical Center, Theresa.Nelson@providence.org

Penny McLain
Providence St. Vincent Medical Center, penny.mclain@providence.org

Follow this and additional works at: https://digitalcommons.psjhealth.org/stvincent-bootcamp
Part of the Nursing Commons

Recommended Citation
Boyles, Peggy; Garland, Gina; Nelson, Theresa; and McLain, Penny, "PSVMC Post Operative Exploratory
Study June-July 2015" (2015). All Nursing Boot Camp Posters. 28.
https://digitalcommons.psjhealth.org/stvincent-bootcamp/28

This Book is brought to you for free and open access by the St. Vincent Medical Center, Portland, OR at Providence
St. Joseph Health Digital Commons. It has been accepted for inclusion in All Nursing Boot Camp Posters by an
authorized administrator of Providence St. Joseph Health Digital Commons. For more information, please contact
digitalcommons@providence.org.

PSVMC Post Operative Exploratory Study
June-July 2015
Authors: Peggy Boyles RN CAPA, Gina Garland RN, Theresa Nelson RN CPAN, Penny McLain RN CPAN
Purpose

Goals

Evaluation

• To explore the current state of management of postoperative
nausea and vomiting (PONV) by anesthesia providers
• To compare the effectiveness of promethazine 6.25 mg to
promethazine 12.5 mg in the post procedural patient
experiencing nausea in Phase I and Phase II
• To compare the known risk factors that precipitate PONV to
the factors that influenced PONV in the study population
• To accurately document nausea and reassessment of
nausea after interventions

• To observe for nausea resolution with differing
doses of promethazine
• To examine the current practice for postoperative
nausea management
• Research known risk factors causing PONV and
compare it to the study population
• Educate staff regarding documentation of nausea
after interventions and audit for compliance

Background

Intervention

• Patients with PONV delay discharge, require more medical
interventions, increase healthcare costs and decrease
patient satisfaction
• Larger doses of promethazine increase sedation in post
operative patients especially in conjunction with opioids
• Promethazine is low cost and has a long elimination half life
• Reassessment of effectiveness of a medication is a JCAHO
requirement

For a period of 2 months, data was collected on the
number of patients that received promethazine 6.25 mg
or 12.5 mg intravenously, and whether nausea resolved
within 30 minutes.
Out of 2200 patients, 85 met inclusion criteria
Compliance of nausea reassessment documentation
was assessed by chart audits in June. Staff was
educated on proper documentation and re-audited in
July.

• 89% of patients with PONV (n=76) received 6.25
mg promethazine. The sample size of
promethazine 12.5mg was too small to be
statistically significant
• The 6.25mg IV promethazine dose resolved the
nausea 86% of the time.
• The sample was comprised of mostly nonsmoking females with an average age of 45
which reaffirmed known risk factors for PONV
• The length of stay increased in both Phase 1 and
Phase ll by 15 min and 50 min respectively for
those receiving promethazine
• Documentation of nausea reassessment
increased by 14% in the month of July

Assessment

.

This study took place in the post surgical area of a 500 bed
magnet facility in the Pacific Northwest. There is variation in
practice for promethazine dosing. Comparing outcomes of
differing doses will allow for recommendations for the smallest
effective dose. Side effects associated with the higher dose
include: increased recovery time, increased healthcare costs,
increased admissions for PONV and decreased patient
satisfaction.
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Next Steps
Partner with anesthesiologists and pharmacists to
begin a controlled clinical trail comparing
decreasing doses of promethazine and/or using a
preemptive dose vs repeating ondansetron.
Review clinical evidence for other nursing
interventions that may relieve nausea in Phase l
and Phase ll post operative patients.
We would like to acknowledge the assistance of Rose Miller BSN RN CAPA and Lynette Savage PhD RN CPHQ

